Search results

• Net zero roadmap for UK manufacturing site

  We became one of the first UK manufacturing sites to develop a 2050 net zero roadmap as part of the UK Government’s Department for Business, Energy and Industrial Strategy ‘Industry of the Future’ programme.

• Life cycle assesment

  Supporting our customers to realise the benefits of LCA meant that in 2022 we began developing our LCA Centre of Excellence, supporting sectors in examining the risks and benefits of their portfolios.

• Human Performance programme

  Our behavioural safety improvement programmes were standardised into a Group-wide Behavioural Safety Observation programme, implemented across all manufacturing sites since 2015.

• Site visit to Sederma Beauty Actives business in France

  17-18 March 2016: Croda International plc hosted a Capital Markets Event for analysts and investors at its Sederma facility near Versailles, France.

• Croda Foundation

  We have taken a big step towards achieving our ambition of expanding the reach of our smart science to permanently improve more lives by funding the Croda Foundation.

• Collaboration to deliver new vaccine adjuvants

  In 2021 we established a strategic collaboration with the Danish government’s life science research institute, Statens Serum Institute (SSI).

• Responsible business

  /Images/Corporate/Corporate V2/Sustainability/Our commitment sustainability image

• Our Board activity in 2025

  An update from Croda’s 2025 Annual Report on Board governance and culture, highlighting leadership, accountability and the values guiding long-term sustainable growth.

• Life Sciences business review - rebalancing Pharma and driving differentiation in Agriculture

  Discover how Life Sciences is rebalancing Pharma and driving differentiation in Agriculture. Exploring innovation, market trends, and strategic growth driving performance in this year’s annual report business review.

• Supporting the next generation of therapeutic vaccines

  Vaccine adjuvants are used to enhance immune response to an antigen, improving the overall efficacy of the vaccine and increasing protection against the target disease.

• Celebrating a century of Croda

  Croda marks 100 years with global celebrations highlighting our people, history, and commitment to our Purpose: Smart science to improve lives™.

• Driving innovation in the Agriculture market

  Through Croda’s acquisition of the Incotec Seed Enhancement business in 2015 and the Plant Impact Biostimulants business in 2018, we are well placed to address some of the challenges in the adoption of biologics.

• CroBioticTM 100

  Surveys indicate that malodour of garments is one of the biggest reasons that consumers choose to wash them.

• Leveraging Group-wide capabilities to accelerate the development of natural active ingredients

  The move in cosmetics towards replacing synthetic ingredients with sustainable alternatives is increasing demand for naturally sourced actives.

• Biodegradable fragrance encapsulation

  Fragrance encapsulation involves advanced delivery systems that allow the timed release of fragrances, critical in various applications such as laundry, fabric softeners and deodorants.

• Croda supports Pfizer-BioNTech COVID-19 vaccine

  Avanti, a company we acquired in 2020, has a strong track record in supplying R&D quantities of lipid-based drug delivery technologies to pharmaceutical companies including those developing mRNA drugs.

• Crodarom expands its Chanac France site

  Crodarom, producer of botanical extracts, is launching its first investment program to expands its Chanac production site location in France.

• 2025 Annual Report

  Croda’s 2025 Annual Report allows you to explore our financial performance, strategic progress, sustainability highlights, and innovation driving long-term growth.

• CrodaTherm helps COVID19 nurses in The Netherlands

  CrodaTherm™ helps reduce heat strain experienced by COVID-19 nurses in The Netherlands

• Key Performance Indicators

  Explore Croda’s key performance indicators for 2025, highlighting progress across financial performance, sustainability and strategic priorities.